Company description
With immunotherapy having unprecedented successes in the clinic and rapidly emerging as the core medical platform for the treatment of cancer, an inaugural Eradicate Cancer conference will be held in Melbourne 15-17 March 2018. The conference title deliberately poses a provocative question and call to action: Eradicate Cancer 2018 - can advanced immunotherapy make it possible?
The conference will embrace the latest technologies and clinical advances, including ‘supercharging’ a patient’s immune system by firstly genetic engineering, empowering T cells with a cancer tracking ’GPS’ creating ‘cancer smart’ killer T cells, and secondly the removal of natural ‘hand brakes’ on immune responses, so they are better able to respond to cancers. These so-called Chimeric Antigen Receptor T cells (CAR-T) and checkpoint blockade inhibitors, respectively, are the pillars to this immuno-oncology revolution. Fundamental to this is the management of treatment related adverse events and the establishment of safe, effective and practical methods for gene editing lymphocytes. It will also evaluate current strategies to rejuvenate and reconstruct the immune system of cancer patients, given the common immunodeficiency they present, as a result of chemotherapy and even natural aging.
We look forward to welcoming you to the meeting! Those interested or involved in the field are encouraged to register their interest.
